Authors: Laude, I Rongieres-Bertrand, C Boyer-Neumann, C Wolf, M Mairovitz, V Hugel, B Freyssinet, JM Frydman, R Meyer, D Eschwege, V

Citation: I. Laude et al., Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight, THROMB HAEM, 85(1), 2001, pp. 18-21

Authors: Ribba, AS Hilbert, L Lavergne, JM Fressinaud, E Boyer-Neumann, C Ternisien, C Juhan-Vague, I Goudemand, J Girma, JP Mazurier, C Meyer, D

Citation: As. Ribba et al., The arginine-552-cysteine (R1315C) mutation within the Al loop of von Willebrand factor induces an abnormal folding with a loss of function resultingin type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor, BLOOD, 97(4), 2001, pp. 952-959

Authors: Wolf, M Boyer-Neumann, C Parent, F Eschwege, V Jaillet, H Meyer, D Simonneau, G

Citation: M. Wolf et al., Thrombotic risk factors in pulmonary hypertension, EUR RESP J, 15(2), 2000, pp. 395-399

Authors: Veyradier, A Fressinaud, E Boyer-Neumann, C Trossaert, M Meyer, D

Citation: A. Veyradier et al., von Willebrand factor ristocetin cofactor activity correlates with platelet function in a high shear stress system, THROMB HAEM, 84(4), 2000, pp. 727-728

Authors: Fressinaud, E Veyradier, A Sigaud, M Boyer-Neumann, C Le Boterff, C Meyer, D

Citation: E. Fressinaud et al., Therapeutic monitoring of von Willebrand disease: interest and limits of aplatelet function analyser at high shear rates, BR J HAEM, 106(3), 1999, pp. 777-783

Authors: Lentschener, C Cottin, P Bouaziz, H Mercier, FJ Wolf, M Aljabi, Y Boyer-Neumann, C Benhamou, D

Citation: C. Lentschener et al., Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion, ANESTH ANAL, 89(3), 1999, pp. 590-597